SUBSCRIBE
SUBSCRIBE
News   Business

CytRx Corporation Reports First Quarter 2012 Financial Results

May 10, 2012 | 
1 min read

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today reported financial results for the three months ended March 31, 2012, and provided a business update.

Earnings
MORE ON THIS TOPIC
Wall Street sign with a background of skyscrapers in Lower Manhattan, New York City
IPO
3 Biotechs Seek Over $700M in Renewed IPO Rush
September 13, 2024
 · 
2 min read
 · 
Annalee Armstrong
Gentilly, France, March 21, 2021: Exterior view of the Sanofi headquarters building. Sanofi is a French multinational company specializing in the health sector
Deals
Sanofi Dips Into Red-Hot Radiopharma Space With $110M Licensing Deal
September 12, 2024
 · 
1 min read
 · 
Annalee Armstrong
Pictured: Facade of Moderna's building in Massachusetts
Pipeline
Moderna Slashes Annual R&D Budget by $1.1B, Eyes 10 Approvals Through 2027
September 12, 2024
 · 
2 min read
 · 
Tristan Manalac
Drug Development
AI Promises: Funding Data Literacy and Reality First
September 12, 2024
 · 
1 min read
 · 
Lori Ellis